Article Text

Download PDFPDF
Survey of Current Practice Patterns in the Treatment of Early-Stage Endometrial Cancer
  1. Elena B. Pereira, MD*,
  2. Brian De, BS,
  3. Valentin Kolev, MD*,
  4. Konstantin Zakashansky, MD,
  5. Sheryl Green, MD,
  6. Peter Dottino, MD* and
  7. Vishal Gupta, MD
  1. *Division of Gynecologic Oncology, Departments of Obstetrics, Gynecology and Reproductive Science, and
  2. Radiation Oncology, Mount Sinai Hospital, Mount Sinai Health System, New York, NY.
  1. Address correspondence and reprint requests to Vishal Gupta, MD, Department of Radiation Oncology, Mount Sinai Hospital, 1184 Fifth Ave, Box 1236, New York, NY 10029. E-mail:


Objectives Our aim was to assess current surgical practices and use of adjuvant therapy in the treatment of FIGO (International Federation of Gynecology and Obstetrics) stage I endometrioid endometrial cancer.

Methods A 19-question survey was developed and sent to all Society of Gynecologic Oncologist members by e-mail. Data were collected anonymously using Internet-based survey software. Respondents were asked questions regarding preoperative evaluation, surgical approach, lymph node dissection (LND), and adjuvant therapy.

Results A total of 1399 surveys were distributed, 320 (23%) members completed the survey. Ninety-seven percent of respondents were gynecologic oncologists or fellows, and 87% treat 30 or more endometrial cancer patients yearly. Respondents were more likely to order preoperative tests such as computed tomography abdomen/pelvis and CA-125 for biopsy-proven grade 3 disease versus grade 1 (82% vs 29%). Robot-assisted laparoscopy was the preferred surgical approach (66%), followed by conventional laparoscopy (21%). Twenty-six percent of respondents perform LND in all cases. Forty-eight percent describe their LND as complete, to the level of the inferior mesenteric artery. Adjuvant therapy was recommended more often with increasing myometrial invasion, tumor grade, and lymphovascular space invasion. Vaginal brachytherapy was the most commonly recommended adjuvant therapy for stage IA. For stage IB, grade 3, positive lymphovascular space invasion disease, respondents were more likely to combine vaginal brachytherapy with external beam radiotherapy and/or chemotherapy. Older patients were more likely to have adjuvant therapy in earlier stages of disease than younger patients.

Conclusions Our findings demonstrate that respondents are individualizing care based on preoperative, intraoperative, and pathologic findings. As expected, adjuvant treatment is recommended for patients with higher stage and grade disease. Robot-assisted hysterectomy and chemotherapy are now commonly used in the management of this disease. We anticipate that new trends will continue to emerge as results from additional studies become available.

  • Endometrial cancer
  • Adjuvant therapy
  • Practice patterns
  • Radiation therapy
  • Surgical techniques

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • The authors declare no conflicts of interest.